Shared Investigator Platform (SIP) | Discussion With A Renowned Oncologist

Cognizant’s Shared Investigator Platform (SIP) introduces an innovative approach to streamlining clinical trials. As the industry’s first global, cloud-based, multi-tenant clinical ecosystem, SIP seamlessly connects sponsors, research sites, and technology providers, allowing them to collaborate efficiently from any location. With a single sign-in, users can access all necessary tools and resources in one centralized platform.

Several leading life sciences companies have adopted SIP, embracing its unified vision of standardized workflows, training, and document management. This shared platform simplifies key processes like clinical trial site selection, start-up communication, and study management. Both sponsors and research sites report increased efficiency, reduced redundancy, and faster trial initiation. The ultimate benefit is a quicker time to market for new therapies, enabling more time to focus on improving patient care.

In the video below, Dr. Claudio Cerchione has an insightful conversation with Cognizant’s Head of Global Medical Affairs, discussing how advancements in technology are addressing the challenges faced by research sites in clinical trials and improving overall efficiency in the clinical research process.